Brief: Takeda Canada British Columbia Reimburses Fruzaqlatm
16/12/2025 14:32
Dec 16 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T: TAKEDA CANADA: BRITISH COLUMBIA REIMBURSES FRUZAQLATM FOR TREATMENT OF METASTATIC COLORECTAL CANCER Source text: ID:nCNWYXkPBa Further company coverage: 4502.T ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Takeda Pharmaceutical
See all newsTakeda launches sleep disorder pill in the US after DEA clearance removes final hurdle (updated)
Brief: Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Takeda Pharmaceutical Company Limited reports results for the quarter ended September 30 - Earnings Summary
Table: Takeda Pharmaceutical Company Limited -6-MTH group results (IFRS)